PolyPeptide Group
PolyPeptide Group is a leading provider of custom/generic peptides for research and pharmaceutical applications with 6 facilities worldwide. Our focus is on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market. With more than 50 years of experience, we are committed to the highest quality of peptide manufacturing for every stage of product development.
PolyPeptide Group
PolyPeptide Group is a leading provider of custom/generic peptides for research and pharmaceutical applications with 6 facilities worldwide. Our focus is on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market. With more than 50 years of experience, we are committed to the highest quality of peptide manufacturing for every stage of product development.
Company name: PolyPeptide Group
Website: www.polypeptide.com
E-mail:
strasbourg@polypeptide.com
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
